Search

everythinglearnresearchcommunity

for

Search:↓

Male and female hair loss have different genetic causes.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Female pattern alopecia is common, starts in late 20s, and is not androgen dependent.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Minoxidil helps treat pattern hair loss in both men and women.

Female hair loss linked to metabolic syndrome, not in males.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

LLLT is a safe, promising hair loss treatment, but more research needed.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

Hospital staff have a higher rate of hair loss than the general population.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Men with severe hair loss may have poorer sperm quality.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Higher BMI links to worse hair loss in Taiwanese men.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Serenoa repens extract in topical products improves hair growth and appearance in male pattern baldness with mild side-effects.

AR gene not major factor in female hair loss; different from male hair loss.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.